Saturday, 30 August 2014

ESC: Novel Heart Failure Drug a Game-Changer (CME/CE)

(MedPage Today) -- An investigational heart failure drug being developed by Novartis cut deaths from heart disease by 20% compared with standard therapy, researchers reported today at the European Society of Cardiology. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment